Yahoo! News: Health News

Health News

• Can home cooking be hazardous to your health? (AP)

  AP - Could your kitchen at home pass a restaurant inspection?

• Botox maker to pay $600M to resolve investigation (AP)

  AP - Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.

  
  

• New test seen as big advance in diagnosing TB (AP)

  AP - Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.

  
  

• Journal editors question sale of diet pill Meridia (AP)

  AP - Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.

• Benefits seen for high-risk women in ovary removal (AP)

  AP - Surgery to remove healthy ovaries gives a triple benefit to high-risk women: It lowers their threat of breast and ovarian cancer, and boosts their chances of living longer, new research suggests.

• Double hand transplant patient shows new hands (AP)

  AP - The recipient of a rare double hand transplant says he feels "fantastic" and can wiggle fingers on both his new hands.

  
  

• Study: Diet Drug Meridia May Boost Heart Risks (Time.com)

  Time.com - A new study finds that some users of the weight-loss pill Meridia may have an increased risk of heart attack or stroke

• For Bonobo Males, Mom Is the Best Wingman (LiveScience.com)

  LiveScience.com - To most human males, the thought of your mother anywhere near your sex life is probably horrifying. Not so for the bonobo, one of our closest primate relatives. A new study confirms that hanging out with mom boosts male bonobos' chances of getting intimate with a fertile female.

• U.S. medical programs missing millions of kids: report (Reuters)

  Reuters - An estimated five million uninsured children in the United States were eligible for Medicaid or the Childrens Health Insurance Program (CHIP) but were not enrolled in either plan, according to a new report.

• Timer may help kids' bladder control problems (Reuters)

  Reuters - Wearing a programmable wristwatch could help children manage their daytime bladder control problems, a new study suggests.

• Seniors Get Boost From Bad News About the Young (HealthDay)

  HealthDay - THURSDAY, Sept. 2 (HealthDay News) -- Older people prefer to read negative news stories about the young, possibly because it makes them feel better about themselves, a new study suggests.

• Bone drugs may raise risk of throat cancer (AP)

  AP - People who take bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study suggests.

• Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice (HealthDay)

  HealthDay - WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to treat high blood sugar in type 2 diabetics may hold some promise in the prevention of tobacco-induced lung cancer, according to extremely preliminary findings in a mouse study.

• Safety groups find no Pampers link to rash cases (Reuters)

  Reuters - Two agencies investigating claims that Procter & Gamble Co's Pampers Dry Max gave children severe diaper rash reported Thursday that they have found no specific cause linking the diapers to rashes.

• HIV discrimination case filed in China (AP)

  AP - A municipal court in central China has accepted the country's first lawsuit alleging work discrimination because of HIV status, state media reported Tuesday.

• Diabetes drug may keep lung cancer at bay (Reuters)

  Reuters - The common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, U.S. researchers said on Wednesday.

  
  

• Health Tip: Coping With Hives (HealthDay)

  HealthDay - (HealthDay News) -- Hives are the result of an allergic reaction. They typically go away without treatment, but can be an itchy nuisance.

• Abbott diet drug study renews calls for U.S. ban (Reuters)

  Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.